FDA materials identify compounded injectable GHK-Cu as a safety concern because of potential immunogenicity, aggregation, peptide-related impurities, and limited human safety data 8
Consistent with past research (Cameron et al., 1993), males had a greater density of ono-week-old BrdU-ir cells compared with 2 h, 24 h, 2w, and 3w after BrdU injection ( p s 0.147) except between 2 and 24 h ( p = 0.156)
This application is earlier-stage than tendon or gut data, but is generating significant interest for post-injury nerve recovery protocols
The blend is still a once-daily injection from the same compounding pharmacy, with broader anti-inflammatory coverage where the surgical field calls for it
Molecular Formula:C62H98N16O22
You can see the general picture in our guide to what peptide therapy costs in Miami and the factors that change the total